Home » ETF » PPH

PPH - VanEck Vectors Pharmaceutical ETF

Stock Price: $69.65 USD 0.24 (0.35%)
Updated Apr 20, 2021 4:00 PM EDT - Market closed
Assets $273.42M
NAV $69.43
Expense Ratio 0.35%
PE Ratio 24.05
Beta (5Y) 0.88
Dividend (ttm) $1.12
Dividend Yield 1.61%
Ex-Dividend Date Apr 1, 2021
1-Year Return -
Trading Day April 20
Last Price $69.65
Previous Close $69.41
Change ($) 0.24
Change (%) 0.35%
Day's Open 69.32
Day's Range 69.26 - 69.67
Day's Volume 51,605
52-Week Range 57.05 - 70.79

Fund Description

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Asset Class
Equity
Sector
Healthcare
Region
Global
Inception Date
Feb 1, 2000
Exchange
NASDAQ
Ticker Symbol
PPH
Index Tracked
MVIS US Listed Pharmaceutical 25 Index

Top 10 Holdings

51.37% of assets
NameSymbolWeight
PfizerPFE5.48%
SanofiSNY5.32%
Bristol-Myers SquibbBMY5.30%
Novartis AG ADRNVSN.MX5.17%
MerckMRK5.11%
AstraZenecaAZN5.10%
Johnson & JohnsonJNJ5.03%
Novo Nordisk A/SNVO4.99%
AbbVieABBV4.95%
ZoetisZTS4.93%
View More Holdings

Dividends

Ex-DividendAmountPay Date
Apr 1, 2021$0.3497Apr 8, 2021
Dec 29, 2020$0.266Jan 5, 2021
Oct 1, 2020$0.249Oct 7, 2020
Jul 1, 2020$0.252Jul 8, 2020
Apr 1, 2020$0.3374Apr 7, 2020
Dec 30, 2019$0.1729Jan 6, 2020
Full Dividend History

News

Hide News
  • All
  • Videos
  • Conversation

Pharmaceutical stocks gained a lot from the pandemic and the race to vaccines, but most of that upside is off the table now. The post 7 Pharmaceutical Stocks That Could Get a Covid Hangover appeared fir...

Other tickers mentioned: IBIO, MRNA, NVAX, OCGN, SRNE
2 weeks ago - InvestorPlace

Coming off a vaccine rally that started in the middle of 2020, the pharmaceutical industry will continue to evolve as technological advances make their way into the sector, which should help ETFs like t...

1 month ago - ETF Trends

Healthcare Q4 results seem robust given that it is the fourth-best sector from a revenue growth look and the sixth-strongest in terms of earnings growth.

Other tickers mentioned: FTXH, IHE, PJP, XPH
2 months ago - Zacks Investment Research

AstraZeneca has agreed to buy rare-disease specialist Alexion Pharmaceuticals for $39 billion. The deal would represent the biggest transaction in pharmaceuticals since 2019.

Other tickers mentioned: BBH, FBT, PBE, PJP
4 months ago - Zacks Investment Research

Sector ETF report for PPH

4 months ago - Zacks Investment Research

With 2020 election season in the rearview mirror, it could be a great time to revisit health and pharmaceutical ETFs, including the VanEck Vectors Pharmaceutical ETF (NASDAQ: PPH). PPH tracks the MVIS U...

4 months ago - ETF Trends

After scuffling amid political uncertainty leading up to Election Day, pharmaceutical stocks and exchange-traded funds are finally perking amid a spate of encouraging news regarding coronavirus vaccine ...

4 months ago - Benzinga

By VanEck Hope Springs Eternal Hopes of a return to normality are increasing after a year of pandemic-induced tumult. News that COVID-19 vaccines developed by Pfizer and BioNTech, and Moderna were more ...

4 months ago - ETF Trends

The broader medical sector should be in the spotlight now on hopes of a coronavirus vaccine and the likelihood of a divided congress.

Other tickers mentioned: FTXH, PJP, PSCH, XHS, XPH
5 months ago - Zacks Investment Research

Easing worries regarding major policy changes are driving the relief rally in the healthcare and biotech spaces in the post-election period.

Other tickers mentioned: IBB, PJP, VHT, XBI, XLV
5 months ago - Zacks Investment Research

The slew of Q3 results have led to mixed trading in pharma ETFs over the past month.

Other tickers mentioned: FTXH, IHE, PJP, XPH
5 months ago - Zacks Investment Research

These trio of pets stocks to buy offers global potential for investors looking to play the growing trend of owning a furry friend. The post 3 Pet Stocks to Buy for Your Furry Friend appeared first on I...

Other tickers mentioned: MRK, PETS
7 months ago - InvestorPlace

Investors looking for compelling valuations don’t have to go deep into the lagging value factor. They can harness some growth with pharmaceuticals ETFs, including the VanEck Vectors Pharmaceutical ETF (...

7 months ago - ETF Trends

For the first four months of the market’s cornavirus recovery, one of the key themes was the dominance of biotech.

Other tickers mentioned: BBH
7 months ago - Benzinga

Total earnings of 66.4% of the healthcare market capitalization that has reported so far are up 4.4% on revenue growth of 4%.

Other tickers mentioned: FTXH, IHE, PJP, XPH
8 months ago - Zacks Investment Research

There are at least a hundred candidates in the COVID-19 vaccine race globally. However, few companies like Moderna, Pfizer and AstraZeneca are showing considerable hope.

Other tickers mentioned: AZN, FTXH, GERM, MRNA, NVAX, PFE, PTH ...
8 months ago - Zacks Investment Research

The VanEck Vectors Pharmaceutical ETF (NASDAQ: PPH) is among the healthcare ETFs recently showing signs of life due in large part to the fight against the coronavirus and although this is an election ye...

9 months ago - ETF Trends

Several companies sit at the forefront of developing a coronavirus vaccine. Gain exposure to each using the following three ETFs.

Other tickers mentioned: PTH, XBI
11 months ago - Investopedia

The best pharmaceutical ETFs for Q3 2020 are KURE, XPH, and PPH.

Other tickers mentioned: KURE, XPH
11 months ago - Investopedia

With Economic Impact Payments beginning to arrive, it's time to put your money to work.

Other tickers mentioned: NOBL, VTV
11 months ago - The Motley Fool

The pharmaceutical industry is often a hotbed of takeover rumors.

Other tickers mentioned: XPH
1 year ago - ETF Trends

Given recovering fundamentals, investors should take advantage of the beaten-down prices. For them, we have highlighted four solid ETF & stock picks each from the industries that are currently undervalu...

Other tickers mentioned: AGN, ARR, COOP, ITB, MORT, TPH, XLF
1 year ago - Zacks Investment Research

Strong results led to solid trading in pharma ETFs over the past week.

Other tickers mentioned: FTXH, IHE, PJP, XPH
1 year ago - Zacks Investment Research

Pharma sector wins in October, making these ETFs and stocks winners.

Other tickers mentioned: DERM, GLYC, IRWD, PJP, RIGL, XPH
1 year ago - Zacks Investment Research

Robust results led to solid trading in pharma ETFs in a month.

Other tickers mentioned: FTXH, IHE, PJP, XPH
1 year ago - Zacks Investment Research

Pharmaceuticals stocks and ETFs, including the VanEck Vectors Pharmaceutical ETF (NASDAQ: PPH), rallied Friday after Senate Majority Leader Mitch McConnell (R-KY) said a House effort to lower drug price...

1 year ago - ETF Trends

Despite robust results, pharma ETFs have been trending downward in a month.

Other tickers mentioned: FTXH, IHE, PJP, XPH
1 year ago - Zacks Investment Research

Despite such robust results, pharma ETFs have been trending downward in a month.

Other tickers mentioned: FTXH, IHE, PJP, XPH
1 year ago - Zacks Investment Research